Literature DB >> 33688964

Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.

Piero Poletti1, Marcello Tirani2,3, Danilo Cereda2, Filippo Trentini1, Giorgio Guzzetta1, Giuliana Sabatino2, Valentina Marziano1, Ambra Castrofino4, Francesca Grosso4, Gabriele Del Castillo4, Raffaella Piccarreta5,6,7, Aida Andreassi2, Alessia Melegaro5,7,8, Maria Gramegna2, Marco Ajelli9,10, Stefano Merler1.   

Abstract

Importance: Solid estimates of the risk of developing symptoms and of progressing to critical disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are key to interpreting coronavirus disease 2019 (COVID-19) dynamics, identifying the settings and the segments of the population where transmission is more likely to remain undetected, and defining effective control strategies. Objective: To estimate the association of age with the likelihood of developing symptoms and the association of age with the likelihood of progressing to critical illness after SARS-CoV-2 infection. Design, Setting, and Participants: This cohort study analyzed quarantined case contacts, identified between February 20 and April 16, 2020, in the Lombardy region of Italy. Contacts were monitored daily for symptoms and tested for SARS-CoV-2 infection, by either real-time reverse transcriptase-polymerase chain reaction using nasopharyngeal swabs or retrospectively via IgG serological assays. Close contacts of individuals with laboratory-confirmed COVID-19 were selected as those belonging to clusters (ie, groups of contacts associated with an index case) where all individuals were followed up for symptoms and tested for SARS-CoV-2 infection. Data were analyzed from February to June 2020. Exposure: Close contact with individuals with confirmed COVID-19 cases as identified by contact tracing operations. Main Outcomes and Measures: Age-specific estimates of the risk of developing respiratory symptoms or fever greater than or equal to 37.5 °C and of experiencing critical disease (defined as requiring intensive care or resulting in death) in SARS-CoV-2-infected case contacts.
Results: In total, 5484 case contacts (median [interquartile range] age, 50 [30-61] years; 3086 female contacts [56.3%]) were analyzed, 2824 of whom (51.5%) tested positive for SARS-CoV-2 (median [interquartile range] age, 53 [34-64] years; 1604 female contacts [56.8%]). The proportion of infected persons who developed symptoms ranged from 18.1% (95% CI, 13.9%-22.9%) among participants younger than 20 years to 64.6% (95% CI, 56.6%-72.0%) for those aged 80 years or older. Most infected contacts (1948 of 2824 individuals [69.0%]) did not develop respiratory symptoms or fever greater than or equal to 37.5 °C. Only 26.1% (95% CI, 24.1%-28.2%) of infected individuals younger than 60 years developed respiratory symptoms or fever greater than or equal to 37.5 °C; among infected participants older than 60 years, 6.6% (95% CI, 5.1%-8.3%) developed critical disease. Female patients were 52.7% (95% CI, 24.4%-70.7%) less likely than male patients to develop critical disease after SARS-CoV-2 infection. Conclusions and Relevance: In this Italian cohort study of close contacts of patients with confirmed SARS-CoV-2 infection, more than one-half of individuals tested positive for the virus. However, most infected individuals did not develop respiratory symptoms or fever. The low proportion of children and young adults who developed symptoms highlights the possible challenges in readily identifying SARS-CoV-2 infections.

Entities:  

Mesh:

Year:  2021        PMID: 33688964     DOI: 10.1001/jamanetworkopen.2021.1085

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  42 in total

1.  Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China.

Authors:  Hengcong Liu; Juanjuan Zhang; Wenhong Zhang; Marco Ajelli; Hongjie Yu; Jun Cai; Xiaowei Deng; Cheng Peng; Xinghui Chen; Juan Yang; Qianhui Wu; Xinhua Chen; Zhiyuan Chen; Wen Zheng; Cécile Viboud
Journal:  BMC Med       Date:  2022-01-31       Impact factor: 8.775

Review 2.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

3.  COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan.

Authors:  Shohei Okamoto; Kazuki Kamimura; Kohei Komamura
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

4.  Treatment efficacy of Lianhua Qingwen capsules for eraly-stage COVID-19.

Authors:  Si-Jia Fan; Jian-Kun Liao; Liu Wei; Bai-Yu Wang; Liu Kai; Du-Xun Tan
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

5.  Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.

Authors:  Shixiong Hu; Wei Wang; Yan Wang; Maria Litvinova; Kaiwei Luo; Lingshuang Ren; Qianlai Sun; Xinghui Chen; Ge Zeng; Jing Li; Lu Liang; Zhihong Deng; Wen Zheng; Mei Li; Hao Yang; Jinxin Guo; Kai Wang; Xinhua Chen; Ziyan Liu; Han Yan; Huilin Shi; Zhiyuan Chen; Yonghong Zhou; Kaiyuan Sun; Alessandro Vespignani; Cécile Viboud; Lidong Gao; Marco Ajelli; Hongjie Yu
Journal:  Nat Commun       Date:  2021-03-09       Impact factor: 14.919

6.  Model-based evaluation of alternative reactive class closure strategies against COVID-19.

Authors:  Quan-Hui Liu; Juanjuan Zhang; Cheng Peng; Maria Litvinova; Shudong Huang; Piero Poletti; Filippo Trentini; Giorgio Guzzetta; Valentina Marziano; Tao Zhou; Cecile Viboud; Ana I Bento; Jiancheng Lv; Alessandro Vespignani; Stefano Merler; Hongjie Yu; Marco Ajelli
Journal:  medRxiv       Date:  2021-04-23

7.  Online Survey of the Impact of COVID-19 Risk and Cost Estimates on Worry and Health Behavior Compliance in Young Adults.

Authors:  Gabriella Imbriano; Emmett M Larsen; Daniel M Mackin; Akaisha Kaixuan An; Christian C Luhmann; Aprajita Mohanty; Jingwen Jin
Journal:  Front Public Health       Date:  2021-03-29

8.  The SIR model towards the data: One year of Covid-19 pandemic in Italy case study and plausible "real" numbers.

Authors:  Ignazio Lazzizzera
Journal:  Eur Phys J Plus       Date:  2021-08-04       Impact factor: 3.911

9.  Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.

Authors:  Kristen K Bjorkman; Tassa K Saldi; Erika Lasda; Leisha Conners Bauer; Jennifer Kovarik; Patrick K Gonzales; Morgan R Fink; Kimngan L Tat; Cole R Hager; Jack C Davis; Christopher D Ozeroff; Gloria R Brisson; Daniel B Larremore; Leslie A Leinwand; Matthew B McQueen; Roy Parker
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

10.  COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings).

Authors:  Germán J Soldano; Juan A Fraire; Jorge M Finochietto; Rodrigo Quiroga
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.